Rezultati 1-20 od 144
GodinaNaslovAutor(i)Tip rezultataMp-kat.
2023Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trialHolmes Frankie A; Moy Beverly; Delaloge Suzette; Chia Stephen KL; Ejlertsen Bent; Mansi Janine; Iwata Hiroji; Gnant Michael; Buyse Marc; Barrios Carlos H;
Silovski Tajana; Šeparović Robert; Bashford Anna; Zotano Guerrero Angel; Dendeluri Neelima; Patt Debra; Gokmen Erhan; Gore Ira; Smith II John W; Loibl Sibylle; Masuda Norikazu; Tomašević Zorica  ; Petrakova Katarina; DiPrimeo Daniel; Wong Alvin; Martin Miguel; Chan Arlene; ExteNET Study Group;
Naučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2022229P Efficiency of SARS-CoV-2 vaccines in breast cancer patients: Single institutional experience from Institute for Oncology and Radiology of Serbia (IORS)Djurmez, Ognjen; Calamac, Marina; Dimitrijevic, M; Vukosavljevic, JG; Serovic, Kristina; Oblakovic-Babic, Jelena S; Stanic, Nemanja S; Minic, Ivana Z  ; Tomasevic, Zorica I  ; Bozovic-Spasojevic, Ivana M  Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2021White blood cell subsets in HER2-positive breast cancer patients treated with trastuzumab in relation to clinical outcomeMatić Ivana Z  ; Grujić Milica; Kolundžija Branka; Damjanović Ana  ; Tomašević Zorica  ; Crnogorac Marija Đ  ; Dzodic Radan ; Filipović Ivana Lj  ; Ždrale Zdravko; Erić-Nikolić Aleksandra  ;
Juranić Zorica  ;
Naučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2020Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC StudyKolberg, Hans-Christian; Colleoni, Marco A; Sawa-Demetriou, G; Santi, Patricia Xavier; Tesch, Hans; Fujiwara, Yasuhiro; Tomasevic, Zorica I  ; Hanes, VladimirNaučni članak
21aM21a - Vodeći međunarodni časopis kategorije M21a
2020Incidence of non-breast cancer neoplasms (non-BCN) diagnosed prior and subsequent to breast cancer (BC): Single institution experience.Tomasevic, Zorica I  ; Tomasevic, Zoran M ; Grujicic, Danica M ; Nikitovic, Marina R  ; Milovanovic, Zorka M  Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2019AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan)Todorovic, Vladimir; ...; Babovic, Nada Lj; ...; Četniković, Bojana; Ceric, Timur; ...; Dzamic, Zoran M  ; Dzodic, Radan R ; Eri, Živka ;
...; Knežević-Ušaj, Slavica F ; Kovcin, Vladimir N; ...; Markovic, Ivan Z; Markovic, Milan; Mijalkovic, Nenad; ...; Pantelic, Aleksandra; Popović, Lazar S  ; Radosavljevic, Davorin Z; ...; Radulovic, Sinisa S; ...; Rosic, Ivana; ...; Stamatović, Ljiljana  ; ...; Tesanovic, Dusanka D; Tomasevic, Zorica I  ; Tomasevic, Zoran M; ...; Vasovic, Suzana; Vicko, Ferenc  ; ...; Zarić, Bojan  ; ...; (broj, koautora 65);
Naučni članak
23M23 - Međunarodni časopis kategorije M23
2019Breast cancer and recurrent thrombosis - Results from prospective single center studyKovač, Mirjana ; Kovac, Zeljko; Tomasević, Zorica  ; Tomić, Branko  ; Gvozdenov, Maja  ; Radojković, Dragica  Informativni prilog
22M22 - Međunarodni časopis kategorije M22
2019Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in SerbiaKrivokuća, Ana  ; Boljević, Ivana ; Jovandic, Stevo; Magic, Zvonko  ; Mandić, Aljoša  ; Tomasevic, Zorica  ; Brankovic-Magic, Mirjana  Naučni članak
21M21 - Vodeći međunarodni časopis kategorije M21
2018Abstract PD3-10: Safety results from a randomized, double-blind, phase 3 study of ABP 980 compared with trastuzumab in patients with breast cancerKolberg, Hans-Christian; Demetriou, Georgia S; Zhang, Nan; Tomasevic, Zorica I  ; Hanes, VladimirKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2018Paclitaxel-induced peripheral neuropathy in patients with operable breast cancerSerovic, Kristina; Tomasevic, Zoran M ; Bozovic-Spasojevic, Ivana M  ; Minic, Ivana Z  ; Oblakovic-Babic, Jelena S; Jokic, Vladimir; Pusica, Aleksandra; Tomasevic, Zorica I  Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2018Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trialvon, Minckwitz Gunter; Colleoni, Marco A; Kolberg, Hans-Christian; Morales, Serafin; Santi, Patricia Xavier; Tomasevic, Zorica I  ; Zhang, Nan; Hanes, VladimirNaučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2018Serbian consensus of neoadjuvant therapy for breast cancer: NeoPULSEPopović, Lazar  ; Tomašević, Zorica  ; Stamatović, Ljiljana  ; Marković, Ivan  ; Matovina-Brko, Gorana ; Buta, Marko  ; Golubović, Andrija ; Selaković, Vladimir; Trifunović, Jasna  ; Mutrezani, Zafir;
Ivanović, Nebojša  ; Nedović, Jasmina; Ninković, Srđan  ; Filipović, Slađana; Cvetanović, Ana  ; Đorđević, Nebojša; Karanikolić, Aleksandar  ; Ivković-Kapicl, Tatjana  ; Vicko, Ferenc  ;
Naučni članak
23M23 - Međunarodni časopis kategorije M23
2017Prognostic importance of steroid receptor status for disease free and overall survival after surgical resection of isolated liver metastasis in breast cancer patientsZegarac, Milan  ; Nikolic. Srdjan  ; Gavrilovic, Dusica; Kolarevic, Daniela ; Jevric, Marko  ; Nikolic-Tomasevic, Zorica  ; Kocic, Milan; Djurisic Igor  ; Inic, Zorka; Markovic, Ivan  ;
Buta, Marko  ; Ninkovic, Srdjan; Dzodic, Radan ;
Naučni članak
23M23 - Međunarodni časopis kategorije M23
2017Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial GroupM. Miguel; F. Holmes; B. Ejlertsen; S. Delaloge; B. Moy; H. Iwata; G. von Minckwitz; S. Chia; J. Mansi; C. Barrios;
Tomašević, Zorica I.  ; M. Gnant...et al.; ExteNET Study Group;
Naučni članak
21a+M21a+ - Vodeći međunarodni časopis kategorije M21a+
2017Cerebellar metastases as the only brain metastatic site and correlation with molecular characteristics of primary breast cancer.Tomašević, Zorica I.  ; Tomasevic Zoran ; Grujicic Danica ; Z. Kovac; Milovanovic Z.orka  ; Minic Ivana  ; Kolarevic DanielaKonferencijski rad
Mp kategorija će biti prikazana naknadno.
2017Characteristics of HER2 3+ metastatic breast cancer patients with long-term benefit of trastuzumab.Tomašević, Zorica I.  ; Tomašević, Zoran ; Minić, Ivana  ; Kolarević, Daniela Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2017Preporuke za praćenje bolesnica sa ranim karcinomom dojke;vodiči i svakodnevna klinička praksaTomašević, Zorica I.  Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2017Biosimilari u onkologiji bazirano na ESMO position paperTomašević, Zorica I.  Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2016Ne-epitelijalni maligni tumori ovarijumaTomašević, Zorica  Konferencijski rad
Mp kategorija će biti prikazana naknadno.
2016Polymorphisms in cancer susceptibility genes XRCC1, RAD51 and TP53 and the risk of breast cancer in Serbian womenKrivokuća, Ana  ; Čavić, Milena  ; Mališić, Emina  ; Dobričić, Jelena ; Kolarević, Daniela ; Tomašević, Zorica  ; Branković-Magić, Mirjana  Naučni članak
22M22 - Međunarodni časopis kategorije M22